UNIVERSITY OF WASHINGTON

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1861-01-01

Employees: 10K

Market Cap: -

Website: https://www.cs.washington.edu

Clinical Trials

Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride With Asparaginase in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

Phase 2

Withdrawn

Conditions: Recurrent T Lymphoblastic Leukemia/Lymphoma
B Lymphoblastic Lymphoma
Recurrent B Lymphoblastic Lymphoma
Refractory T Lymphoblastic Lymphoma
T Lymphoblastic Lymphoma
B Acute Lymphoblastic Leukemia
Recurrent Adult Acute Lymphoblastic Leukemia
Refractory B Lymphoblastic Lymphoma
T Acute Lymphoblastic Leukemia

Interventions: Drug: Asparaginase
Drug: Cyclophosphamide
Drug: Doxorubicin Hydrochloride
Drug: Etoposide
Drug: Imatinib Mesylate
Other: Laboratory Biomarker Analysis
Drug: Prednisone
Biological: Rituximab
Drug: Vincristine Sulfate

First Posted Date: 2015-09-02

Last Posted Date: 2018-11-14

Lead Sponsor: University of Washington

Registration Number: NCT02538926

Locations: 🇺🇸
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States

Niclosamide and Enzalutamide in Treating Patients With Castration-Resistant, Metastatic Prostate Cancer

Phase 1

Completed

Conditions: Castration Levels of Testosterone
Castration-Resistant Prostate Carcinoma
Metastatic Prostate Carcinoma
Recurrent Prostate Carcinoma
Stage IV Prostate Adenocarcinoma

Interventions: Drug: Enzalutamide
Other: Laboratory Biomarker Analysis
Drug: Niclosamide
Other: Pharmacological Study

First Posted Date: 2015-08-25

Last Posted Date: 2018-04-18

Lead Sponsor: University of Washington

Target Recruit Count: 5

Registration Number: NCT02532114

Locations: 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

Text Messaging to Improve HIV Testing Among Young Women in Kenya

Not Applicable

Completed

Conditions: HIV Infection

Interventions: Behavioral: Weekly HIV sensitization text messages

First Posted Date: 2015-08-18

Last Posted Date: 2015-08-18

Lead Sponsor: University of Washington

Target Recruit Count: 600

Registration Number: NCT02527135

Locations: 🇰🇪
Partners in Health and Research Development (PHRD), Nairobi, Kenya

Copper IUD Treatment Observation Study

Phase 4

Completed

Conditions: Menorrhagia

Interventions: Drug: Placebo
Drug: Naproxen

First Posted Date: 2015-08-10

Last Posted Date: 2020-10-14

Lead Sponsor: University of Washington

Target Recruit Count: 34

Registration Number: NCT02519231

Locations: 🇺🇸
Harborview Medical Center, Seattle, Washington, United States
🇺🇸
John H Stroger Jr Hospital of Cook County, Chicago, Illinois, United States
🇺🇸
UW Neighborhood Clinic Northgate, Seattle, Washington, United States

and more 2 locations

Health Research Participation: Experiences and Decisions of Military Members

Conditions: Life Experiences
Decision Making

First Posted Date: 2015-08-10

Last Posted Date: 2017-05-30

Lead Sponsor: University of Washington

Target Recruit Count: 50

Registration Number: NCT02518893

Locations: 🇺🇸
Madigan Army Medical Center, Tacoma, Washington, United States

WEE1 Inhibitor MK-1775, Docetaxel, and Cisplatin Before Surgery in Treating Patients With Borderline Resectable Stage III-IVB Squamous Cell Carcinoma of the Head and Neck

Phase 1

Completed

Conditions: Head and Neck Squamous Cell Carcinoma

Interventions: Drug: Cisplatin
Drug: Docetaxel
Other: Laboratory Biomarker Analysis
Other: Pharmacological Study
Procedure: Therapeutic Conventional Surgery
Drug: WEE1 Inhibitor AZD1775

First Posted Date: 2015-07-24

Last Posted Date: 2019-03-13

Lead Sponsor: University of Washington

Target Recruit Count: 12

Registration Number: NCT02508246

Locations: 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

Connection to Care: Pilot Study of a Mobile Health Tool for Patients With Depression and Anxiety

Not Applicable

Completed

Conditions: Depression
Anxiety

Interventions: Behavioral: App for smartphone
Device: smartphone

First Posted Date: 2015-07-14

Last Posted Date: 2017-12-02

Lead Sponsor: University of Washington

Target Recruit Count: 18

Registration Number: NCT02497755

Locations: 🇺🇸
University of Washington Neighborhood Clinic, Ravenna, Seattle, Washington, United States

Enzalutamide in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma

Phase 2

Terminated

Conditions: Ann Arbor Stage I Mantle Cell Lymphoma
Ann Arbor Stage II Mantle Cell Lymphoma
Ann Arbor Stage III Mantle Cell Lymphoma
Ann Arbor Stage IV Mantle Cell Lymphoma
Recurrent Mantle Cell Lymphoma
Refractory Mantle Cell Lymphoma

Interventions: Drug: Enzalutamide
Other: Laboratory Biomarker Analysis

First Posted Date: 2015-07-02

Last Posted Date: 2021-08-10

Lead Sponsor: University of Washington

Target Recruit Count: 8

Registration Number: NCT02489123

Locations: 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

Brain Regulation of Appetite in Twins

Completed

Conditions: Appetite
Obesity

Interventions: Device: Functional Magnetic Resonance Imaging
Radiation: Dual Energy X-ray absorptiometry
Other: Questionnaires
Other: Mood and Appetite Ratings
Other: Test Meals
Other: Computer Tests
Procedure: Intravenous Catheter (IV) placement

First Posted Date: 2015-06-29

Last Posted Date: 2017-10-27

Lead Sponsor: University of Washington

Target Recruit Count: 122

Registration Number: NCT02483663

Locations: 🇺🇸
University of Washington, Seattle, Washington, United States

MS Symptom Management Study

Not Applicable

Completed

Conditions: Multiple Sclerosis
Chronic Pain
Fatigue

Interventions: Behavioral: Intervention #3
Behavioral: Intervention #2
Behavioral: Intervention #1

First Posted Date: 2015-06-18

Last Posted Date: 2017-12-26

Lead Sponsor: University of Washington

Target Recruit Count: 37

Registration Number: NCT02474940

Locations: 🇺🇸
University of Washington, Ninth and Jefferson Building, Seattle, Washington, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy